Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken through the NICE health technology evaluation methods review to assess the effect of the (a) reference (b) non-reference discount rate on gene therapies.
The National Institute for Health and Care Excellence (NICE) is an independent body and is therefore responsible for its own methods and processes. The discount rates applied by NICE in its health technology assessments are specified in its methods guides. NICE will carry out three public consultations as part of its methods review. The most recent consultation being 6 November to 18 December on the case for change to its methods.